Funding Announcements and Opportunities

Funding Announcements

September 19, 2018
HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Research Sites) (UM1 - Clinical Trial Required) (RFA-DA-19-016)
Estimated Publication Date of FOA: November 11, 2018

September 19, 2018
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) (RFA-NS-18-043)
Estimabed Publication Date of FOA: October 27, 2018

August 23, 2018
Notice of Intent to Publish a FOA for Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) (NOT-NS-18-080)
Estimated Publication Date of FOA: October 27, 2018

July 23, 2018
Notice of Intent to Publish a FOA for Analytical and Clinical Validation of Biomarkers, Biomarker Signatures, and Endpoints for Pain Indications (R61/R33) (NOT-NS-18-074)
Estimated Publication Date of FOA: September 2, 2018

July 23, 2018
Notice of Change of Requirements and Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction (NOT-NS-18-076)

July 18, 2018
Notice of Intent to Publish a FOA for Data Coordinating Center for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1) (NOT-DA-18-025)
Estimated Publication Date of FOA: September 17, 2018

July 18, 2018
Notice of Intent to Publish a FOA for Research Site for the HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (UM1) (NOT-DA-18-026)
Estimated Publication Date of FOA: September 17, 2018

July 9, 2018
Notice of Change of Requirements for RFA-DA-19-002, "Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) (NOT-DA-18-016)

June 14, 2018
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network for Pain - Data Coordinating Center (U24 Clinical Trial Not Allowed)

June 14, 2018
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network for Pain - Data Coordinating Center (U24 Clinical Trial Not Allowed)

June 14, 2018
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network for Pain - Clinical Coordinating Center (U24 Clinical Trial Optional) 

New Funding Opportunities

Notice HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Data Coordinating Center) (UM1- Clinical Trials Not Allowed)
Notice Number RFA-DA-19-017
Earliest Submission Date November 11, 2018
Letter of Intent Due Date November 11, 2018
Application Due Date

December 11, 2018 , by 5:00 PM local time of applicant organization

 
Notice Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-046
Earliest Submission Date October 27, 2018
Application Due Date

November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization

Notice Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
Notice Number RFA-NS-18-042
Earliest Submission Date October 27, 2018
Application Due Date

November 27, 2018; February 11, 2019; July 11, 2019; November 12, 2019, by 5:00 PM local time of applicant organization

Notice Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional)
Notice Number RFA-RM-18-031
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional)
Notice Number RFA-RM-18-032
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1 Clinical Trial Optional)
Notice Number RFA-RM-18-033
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional)
Notice Number RFA-RM-18-034
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24 Clinical Trial Optional)
Notice Number RFA-RM-18-035
Earliest Submission Date September 24, 2018
Application Due Date

October 24, 2018, by 5:00 PM local time of applicant organization.

Notice Administrative Supplements for Validation of Novel Non-Addictive Pain Targets (Clinical Trials Not Allowed)
Notice Number NOT-NS-18-073
Release Date August 23, 2018
Notice Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-041
Earliest Submission Date October 27, 2018
Application Due Date

November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization.

Notice NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
ID Number RFA-DA-18-020
Earliest Submission Date June 25, 2018
Application Due Date July 25, 2018; July 25, 2019, July 25, 2020), by 5:00 PM local time of applicant organization.
Notice Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
ID Number RFA-DA-19-002
Application Due Date Rolling basis beginning on January 25, 2018
Notice Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
ID Number PAR-18-219
Application Due Date March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization
Notice Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
ID Number PAR-18-218
Application Due Date March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization.

Funded Projects

This page last reviewed on September 24, 2018